NADAC acquisition cost data for IVERMECTIN 1% CREAM. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00574210745 | $5.01 | 2022-12-21 | Rx |
| 00591405289 | $5.01 | 2022-12-21 | Rx |
| 66993094848 | $5.01 | 2022-12-21 | Rx |
| 00574210745 | $5.01 | 2022-12-21 | Rx |
| 00591405289 | $5.01 | 2022-12-21 | Rx |
| 66993094848 | $5.01 | 2022-12-21 | Rx |
Generic: IVermectin | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $3.6M | 75,387 | 53,434 | $4.09 |
| 2020 | $6.7M | 102,158 | 76,571 | $4.19 |
| 2021 | $23.4M | 265,316 | 186,161 | $3.88 |
| 2022 | $12.1M | 90,384 | 62,946 | $4.70 |
| 2023 | $11.4M | 63,360 | 40,953 | $5.43 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.